<b>Objectives</b><br/>The prognostic significance of CDC42 effector protein 2 (CDC42EP2) and its association with tumor-infiltrating immune cells (TIICs) have not been explored in liver hepatocellular carcinoma (LIHC). This study aims to assess the potential prognostic value of CDC42EP2 by conducting a comprehensive analysis of online databases pertaining to LIHC. Methods: We evaluated the potential of CDC42EP2 as a prognostic biomarker by utilizing online databases such as TIMER, GEPIA2, KM, OSlihc, HPA, and LinkedOmics. Results: In LIHC, we observed that the mRNA and protein expression of CDC42EP2 were upregulated compared to normal tissues. Upregulated CDC42EP2 expression was associated with a worse prognosis based on the clinicopathological characteristics of patients with LIHC. Furthermore, CDC42EP2 was positively associated with TIICs. In the co-expression and functional enrichment analyses of CDC42EP2, 11,416 genes showed positive associations with CDC42EP2 while 8,008 genes showed negative associations. CDC42EP2-related co-expression genes were involved in protein localization to the endoplasmic reticulum, translational initiation, and RNA catabolic processes in gene set enrichment analysis-Gene Ontology (GSEAGO), and regulated the ribosome, spliceosome, and primary immune deficiency in the GSEAKyoto Encyclopedia of Genes and Genomes (KEGG) pathway. In a survival map, 23 and 17 genes that exhibited positive associations with CDC42EP2 showed a significant hazard ratio (HR) for overall survival and disease-free survival, respectively. Conclusion: Our findings demonstrated that CDC42EP2 is a novel prognostic biomarker and a potential tumor immune therapeutic target in patients with LIHC.
<b>Objectives</b><br/>The coronavirus disease 2019 (COVID-19) pandemic, caused by a dynamic virus, has had a profound global impact. Despite declining global COVID-19 cases and mortality rates, the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants remains a major concern. This study provides a comprehensive analysis of the genomic sequences of SARS-CoV-2 within the Bhutanese population during the pandemic. The primary aim was to elucidate the molecular epidemiology and evolutionary patterns of SARS-CoV-2 in Bhutan, with a particular focus on genetic variations and lineage dynamics. Methods: Whole-genome sequences of SARS-CoV-2 collected from Bhutan between May 2020 and February 2023 (n=135) were retrieved from the Global Initiative on Sharing All Influenza Database. Results: The SARS-CoV-2 variants in Bhutan were predominantly classified within the Nextstrain clade 20A (31.1%), followed by clade 21L (20%) and clade 22D (15.6%). We identified 26 Pangolin lineages with variations in their spatial and temporal distribution. Bayesian time-scaled phylogenetic analysis estimated the time to the most recent common ancestor as February 15, 2020, with a substitution rate of 0.97×10–3 substitutions per site per year. Notably, the spike glycoprotein displayed the highest mutation frequency among major viral proteins, with 116 distinct mutations, including D614G. The Bhutanese isolates also featured mutations such as E484K, K417N, and S477N in the spike protein, which have implications for altered viral properties. Conclusion: This is the first study to describe the genetic diversity of SARS-CoV-2 circulating in Bhutan during the pandemic, and this data can inform public health policies and strategies for preventing future outbreaks in Bhutan.
<b>Objectives</b><br/>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). The COVID-19 incidence and mortality rates are low in Nigeria compared to global trends. This research mapped the evolution of SARS-CoV-2 circulating in Nigeria and globally to determine whether the Nigerian isolates are genetically distinct from strains circulating in regions of the world with a high disease burden. Methods: Bayesian phylogenetics using BEAST 2.0, genetic similarity analyses, and genomewide mutational analyses were used to characterize the strains of SARS-CoV-2 isolated in Nigeria. Results: SARS-CoV-2 strains isolated in Nigeria showed multiple lineages and possible introductions from Europe and Asia. Phylogenetic clustering and sequence similarity analyses demonstrated that Nigerian isolates were not genetically distinct from strains isolated in other parts of the globe. Mutational analysis demonstrated that the D614G mutation in the spike protein, the P323L mutation in open reading frame 1b (and more specifically in NSP12), and the R203K/ G204R mutation pair in the nucleocapsid protein were most prevalent in the Nigerian isolates. Conclusion: The SARS-CoV-2 strains in Nigeria were neither phylogenetically nor genetically distinct from virus strains circulating in other countries of the world. Thus, differences in SARS-CoV-2 genomes are not a plausible explanation for the attenuated COVID-19 outcomes in Nigeria.
Citations
Citations to this article as recorded by
A retrospective whole genome sequencing of SARS-CoV-2 isolate from respiratory sample of an individual from Ota – Ogun State, Nigeria Olajumoke Olufunmilayo Joseph, Samuel Olatunde Dahunsi, Anthony Okoh Gene Reports.2024; 37: 102032. CrossRef
Yersinia pestis, the cause of plague and a potential biological weapon, has always been a threatening pathogen. Some strains of Y. pestis have varying degrees of antibiotic resistance. Thus, this systematic review was conducted to alert clinicians to this pathogen’s potential antimicrobial resistance. A review of the literature was conducted for experimental reports and systematic reviews on the topics of plague, Y. pestis, and antibiotic resistance. From 1995 to 2021, 7 Y. pestis isolates with 4 antibiotic resistance mechanisms were reported. In Y. pestis 17/95, 16/95, and 2180H, resistance was mediated by transferable plasmids. Each plasmid contained resistance genes encoded within specific transposons. Strain 17/95 presented multiple drug resistance, since plasmid 1202 contained 10 resistance determinants. Strains 16/95 and 2180H showed single antibiotic resistance because both additional plasmids in these strains carried only 1 antimicrobial determinant. Strains 12/87, S19960127, 56/13, and 59/13 exhibited streptomycin resistance due to an rpsl gene mutation, a novel mechanism that was discovered recently. Y. pestis can acquire antibiotic resistance in nature not only via conjugative transfer of antimicrobial-resistant plasmids from other bacteria, but also by gene point mutations. Global surveillance should be strengthened to identify antibiotic-resistant Y. pestis strains by whole-genome sequencing and drug susceptibility testing.
Citations
Citations to this article as recorded by
Live Plague Vaccine Development: Past, Present, and Future Andrey P. Anisimov, Anastasia S. Vagaiskaya, Alexandra S. Trunyakova, Svetlana V. Dentovskaya Vaccines.2025; 13(1): 66. CrossRef
Seek and you shall find: Yersinia enterocolitica in Ireland’s drinking water James Powell, Maureen Daly, Nuala H. O’Connell, Colum P. Dunne Irish Journal of Medical Science (1971 -).2024; 193(4): 1885. CrossRef
A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague Xiao Guo, Youquan Xin, Zehui Tong, Shiyang Cao, Yuan Zhang, Gengshan Wu, Hongyan Chen, Tong Wang, Yajun Song, Qingwen Zhang, Ruifu Yang, Zongmin Du, Gregory P. Priebe PLOS Pathogens.2024; 20(3): e1012129. CrossRef
Interaction between Yersinia pestis Ail Outer Membrane Protein and the C-Terminal Domain of Human Vitronectin Laurine Vasseur, Florent Barbault, Antonio Monari The Journal of Physical Chemistry B.2024; 128(16): 3929. CrossRef
Integrated Computational Analysis of Physicochemical Features, Biological Properties, Kinase Target Prediction and Biotransformation Pathways in Drug Discovery Mohamed Sabri Bensaad, Dhiya Eddine Bensaad, Mohamed Amine Kahoul, Dania S. Waggas, Roua S. Baty, Rokayya Sami, Hamsa Jameel Banjer, Siraj B. Alharthi, Ruqaiah I. Bedaiwi, Zeyad M. Alharbi, Mohammad A. Alanazi, Nouf H. Alsubhi, Ashwaq M. Al-Nazawi, Nada A International Journal of Pharmacology.2024; 20(5): 748. CrossRef
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision Maria Vittoria Ristori, Valerio Guarrasi, Paolo Soda, Nicola Petrosillo, Fiorella Gurrieri, Umile Giuseppe Longo, Massimo Ciccozzi, Elisabetta Riva, Silvia Angeletti Genes.2024; 15(7): 908. CrossRef
Screening of promising molecules against potential drug targets in Yersinia pestis by integrative pan and subtractive genomics, docking and simulation approach Lei Chen, Lihu Zhang, Yanping Li, Liang Qiao, Suresh Kumar Archives of Microbiology.2024;[Epub] CrossRef
Plasmonic-Enhanced Colorimetric Lateral Flow Immunoassays Using Bimetallic Silver-Coated Gold Nanostars Supriya Atta, Yuanhao Zhao, Sebastian Sanchez, Deven Seedial, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Marcellene A. Gates-Hollingsworth, Kathryn J Pflughoeft, Jian Gu, Douglas C. Montgomery, David P. AuCoin, Frederic Zenhausern, Tuan Vo-Din ACS Applied Materials & Interfaces.2024; 16(40): 54907. CrossRef
Madagascar’s Plague: One Health Research Aims to Slow Its Spread Wendee Nicole Environmental Health Perspectives.2024;[Epub] CrossRef
The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice Emily K. Hendrix, Jian Sha, Paul B. Kilgore, Blake H. Neil, Atul K. Verma, Ashok K. Chopra Vaccines.2024; 12(12): 1361. CrossRef
Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies Arnaud Avril, Sophie Guillier, Christine Rasetti-Escargueil Microorganisms.2024; 12(12): 2622. CrossRef
Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens Moshe Aftalion, Avital Tidhar, Yaron Vagima, David Gur, Ayelet Zauberman, Tzvi Holtzman, Arik Makovitzki, Theodor Chitlaru, Emanuelle Mamroud, Yinon Levy Vaccines.2023; 11(3): 581. CrossRef
Antibiotic resistance in Neisseria gonorrhoeae: broad-spectrum drug target identification using subtractive genomics Umairah Natasya Mohd Omeershffudin, Suresh Kumar Genomics & Informatics.2023; 21(1): e5. CrossRef
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague Sergei S. Biryukov, Hua Wu, Jennifer L. Dankmeyer, Nathaniel O. Rill, Christopher P. Klimko, Kristi A. Egland, Jennifer L. Shoe, Melissa Hunter, David P. Fetterer, Ju Qiu, Michael L. Davies, Christoph L. Bausch, Eddie J. Sullivan, Thomas Luke, Christopher Antibodies.2023; 12(2): 33. CrossRef
New Bacteriophages with Podoviridal Morphotypes Active against Yersinia pestis: Characterization and Application Potential Tamar Suladze, Ekaterine Jaiani, Marina Darsavelidze, Maia Elizbarashvili, Olivier Gorge, Ia Kusradze, Tamar Kokashvili, Nino Lashkhi, George Tsertsvadze, Nino Janelidze, Svetlana Chubinidze, Marina Grdzelidze, Shota Tsanava, Eric Valade, Marina Tediashvi Viruses.2023; 15(7): 1484. CrossRef
Characterization of Mu-Like
Yersinia
Phages Exhibiting Temperature Dependent Infection
Biao Meng, Zhizhen Qi, Xiang Li, Hong Peng, Shanzheng Bi, Xiao Wei, Yan Li, Qi Zhang, Xiaoqing Xu, Haihong Zhao, Xiaoyan Yang, Changjun Wang, Xiangna Zhao, Olaya Rendueles Microbiology Spectrum.2023;[Epub] CrossRef
Ancient
Yersinia pestis
genomes lack the virulence-associated Ypf
Φ
prophage present in modern pandemic strains
Joanna H. Bonczarowska, Julian Susat, Ben Krause-Kyora, Dorthe Dangvard Pedersen, Jesper Boldsen, Lars Agersnap Larsen, Lone Seeberg, Almut Nebel, Daniel Unterweger Proceedings of the Royal Society B: Biological Sci.2023;[Epub] CrossRef
A situation analysis of the current plague outbreak in the Demographic Republic of Congo and counteracting strategies – Correspondence Ranjit Sah, Abdullah Reda, Rachana Mehta, Ranjan K. Mohapatra, Kuldeep Dhama International Journal of Surgery.2022; 105: 106885. CrossRef
Antimicrobial resistance in Klebsiella pneumoniae: identification of bacterial DNA adenine methyltransferase as a novel drug target from hypothetical proteins using subtractive genomics Umairah Natasya Mohd Omeershffudin, Suresh Kumar Genomics & Informatics.2022; 20(4): e47. CrossRef
<sec><b>Objectives</b>
<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has been rapidly spreading worldwide. Although the causal relationship among mutations and the features of SARS-CoV-2 such as rapid transmission, pathogenicity, and tropism, remains unclear, our results of genomic mutations in SARS-CoV-2 may help to interpret the interaction between genomic characterization in SARS-CoV-2 and infectivity with the host.</p></sec>
<sec><b>Methods</b>
<p>A total of 4,254 genomic sequences of SARS-CoV-2 were collected from the Global Initiative on Sharing all Influenza Data (GISAID). Multiple sequence alignment for phylogenetic analysis and comparative genomic approach for mutation analysis were conducted using Molecular Evolutionary Genetics Analysis (MEGA), and an in-house program based on Perl language, respectively.</p></sec>
<sec><b>Results</b>
<p>Phylogenetic analysis of SARS-CoV-2 strains indicated that there were 3 major clades including S, V, and G, and 2 subclades (G.1 and G.2). There were 767 types of synonymous and 1,352 types of non-synonymous mutation. ORF1a, ORF1b, S, and N genes were detected at high frequency, whereas ORF7b and E genes exhibited low frequency. In the receptor-binding domain (RBD) of the S gene, 11 non-synonymous mutations were observed in the region adjacent to the angiotensin converting enzyme 2 (ACE2) binding site.</p></sec>
<sec><b>Conclusion</b>
<p>It has been reported that the rapid infectivity and transmission of SARS-CoV-2 associated with host receptor affinity are derived from several mutations in its genes. Without these genetic mutations to enhance evolutionary adaptation, species recognition, host receptor affinity, and pathogenicity, it would not survive. It is expected that our results could provide an important clue in understanding the genomic characteristics of SARS-CoV-2.</p></sec>
Citations
Citations to this article as recorded by
Unraveling the impact of ORF3a Q57H mutation on SARS-CoV-2: insights from molecular dynamics Md. Jahirul Islam, Md. Siddik Alom, Md. Shahadat Hossain, Md Ackas Ali, Shaila Akter, Shafiqul Islam, M. Obayed Ullah, Mohammad A. Halim Journal of Biomolecular Structure and Dynamics.2024; 42(18): 9753. CrossRef
Three-Dimensional Structural Stability and Local Electrostatic Potential at Point Mutations in Spike Protein of SARS-CoV-2 Coronavirus Svetlana H. Hristova, Alexandar M. Zhivkov International Journal of Molecular Sciences.2024; 25(4): 2174. CrossRef
SARS-CoV-2-ORF3a variant Q57H reduces its pro-apoptotic activity in host cells Maria Landherr, Iuliia Polina, Michael W. Cypress, Isabel Chaput, Bridget Nieto, Bong Sook Jhun, Jin O-Uchi F1000Research.2024; 13: 331. CrossRef
Genome sequencing of SARS-Co-V-2 reveals mutations including F559I and V781D in S protein and LI123-124L in the nsp6 in 21K and 21L clades Mohamed G. Seadawy, Mohamed I. Marei, Marwa Mohanad, Ahmed A. Hmed, Ahmed R. Sofy VirusDisease.2024; 35(3): 400. CrossRef
Stability of Neutralizing Antibody of PastoCoAd Vaccine Candidates against a Variant of Concern of SARS-CoV-2 in Animal Models Mohammad Panahi, Ali Teimoori, Saber Esmaeili, Hossein Aminianfar, Alireza Milani, Seyed Younes Hosseini, Parisa Esmaeili, Alireza Biglari, Kazem Baesi Iranian Biomedical Journal.2024; 28(4): 214. CrossRef
DETERMINATION OF E PROTEIN MUTATION IN SARS-COV-2 VIRUS ISOLATES A. T. Zhunushov, A. B. Berdibaeva Biosafety and Biotechnology.2024; (16): 18. CrossRef
Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic Mohammad Khalid, David Murphy, Maryam Shoai, Jonahunnatha Nesson George-William, Yousef Al-ebini Gene.2023; 851: 147020. CrossRef
SARS-CoV-2 mutations on diagnostic gene targets in the second wave in Zimbabwe: A retrospective genomic analysis C Nyagupe, L de Oliveira Martins, H Gumbo, T Mashe, T Takawira, KK Maeka, A Juru, LK Chikanda, AR Tauya, AJ Page, RA Kingsley, R Simbi, J Chirenda, J Manasa, V Ruhanya, RT Mavenyengwa South African Medical Journal.2023; 113(3): 141. CrossRef
A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge Gerrit Koopman, Mario Amacker, Toon Stegmann, Ernst J. Verschoor, Babs E. Verstrepen, Farien Bhoelan, Denzel Bemelman, Kinga P. Böszörményi, Zahra Fagrouch, Gwendoline Kiemenyi-Kayere, Daniella Mortier, Dagmar E. Verel, Henk Niphuis, Roja Fidel Acar, Ivan Scientific Reports.2023;[Epub] CrossRef
Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers Karen Cortés-Sarabia, Vianey Guzman-Silva, Karla Montserrat Martinez-Pacheco, Jesús Alberto Meza-Hernández, Víctor Manuel Luna-Pineda, Marco Antonio Leyva-Vázquez, Amalia Vences-Velázquez, Fredy Omar Beltrán-Anaya, Oscar Del Moral-Hernández, Berenice Illa Viruses.2023; 15(4): 966. CrossRef
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants Junhyung Cho, Younmin Shin, Jeong-Sun Yang, Jun Won Kim, Kyung-Chang Kim, Joo-Yeon Lee Antiviral Research.2023; 214: 105609. CrossRef
Genetic Analysis and Epitope Prediction of SARS-CoV-2 Genome in Bahia, Brazil: An In Silico Analysis of First and Second Wave Genomics Diversity Gabriela Andrade, Guilherme Matias, Lara Chrisóstomo, João da Costa-Neto, Juan Sampaio, Arthur Silva, Isaac Cansanção COVID.2023; 3(5): 655. CrossRef
Natural selection shapes the evolution of SARS-CoV-2 Omicron in Bangladesh Mohammad Tanbir Habib, Saikt Rahman, Mokibul Hassan Afrad, Arif Mahmud Howlader, Manjur Hossain Khan, Farhana Khanam, Ahmed Nawsher Alam, Emran Kabir Chowdhury, Ziaur Rahman, Mustafizur Rahman, Tahmina Shirin, Firdausi Qadri Frontiers in Genetics.2023;[Epub] CrossRef
Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing Praiscillia Kia, Eric Katagirya, Fredrick Elishama Kakembo, Doreen Ato Adera, Moses Luutu Nsubuga, Fahim Yiga, Sharley Melissa Aloyo, Brendah Ronah Aujat, Denis Foe Anguyo, Fred Ashaba Katabazi, Edgar Kigozi, Moses L. Joloba, David Patrick Kateete Scientific Reports.2023;[Epub] CrossRef
Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor‐binding domain mutations: Receptor affinity versus neutralization of receptor interaction Monique Vogel, Gilles Augusto, Xinyue Chang, Xuelan Liu, Daniel Speiser, Mona O. Mohsen, Martin F. Bachmann Allergy.2022; 77(1): 143. CrossRef
Peptides and peptidomimetics as therapeutic agents for Covid‐19 Achyut Dahal, Jafrin Jobayer Sonju, Konstantin G. Kousoulas, Seetharama D. Jois Peptide Science.2022;[Epub] CrossRef
Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function Sk. Sarif Hassan, Kenneth Lundstrom, Ángel Serrano-Aroca, Parise Adadi, Alaa A.A. Aljabali, Elrashdy M. Redwan, Amos Lal, Ramesh Kandimalla, Tarek Mohamed Abd El-Aziz, Pabitra Pal Choudhury, Gajendra Kumar Azad, Samendra P. Sherchan, Gaurav Chauhan, Murta International Journal of Biological Macromolecules.2022; 194: 128. CrossRef
COVID-19: comprehensive review on mutations and current vaccines Ananda Vardhan Hebbani, Swetha Pulakuntla, Padmavathi Pannuru, Sreelatha Aramgam, Kameswara Rao Badri, Vaddi Damodara Reddy Archives of Microbiology.2022;[Epub] CrossRef
Prediction of the Effects of Nonsynonymous Variants on SARS-CoV-2 Proteins Boon Zhan Sia, Wan Xin Boon, Yoke Yee Yap, Shalini Kumar, Chong Han Ng F1000Research.2022; 11: 9. CrossRef
Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China Xiao-wen Cheng, Jie Li, Lu Zhang, Wen-jun Hu, Lu Zong, Xiang Xu, Jin-ping Qiao, Mei-juan Zheng, Xi-wen Jiang, Zhi-kun Liang, Yi-fan Zhou, Ning Zhang, Hua-qing Zhu, Yuan-hong Xu Frontiers in Medicine.2022;[Epub] CrossRef
Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification OLUWAKEMI EBENEZER, MICHAEL SHAPI Acta Pharmaceutica.2022; 72(2): 159. CrossRef
Genomic surveillance of SARS-CoV-2 in the state of Delaware reveals tremendous genomic diversity Karl R. Franke, Robert Isett, Alan Robbins, Carrie Paquette-Straub, Craig A. Shapiro, Mary M. Lee, Erin L. Crowgey, Pierre Roques PLOS ONE.2022; 17(1): e0262573. CrossRef
The importance of accessory protein variants in the pathogenicity of SARS-CoV-2 Sk. Sarif Hassan, Pabitra Pal Choudhury, Guy W. Dayhoff, Alaa A.A. Aljabali, Bruce D. Uhal, Kenneth Lundstrom, Nima Rezaei, Damiano Pizzol, Parise Adadi, Amos Lal, Antonio Soares, Tarek Mohamed Abd El-Aziz, Adam M. Brufsky, Gajendra Kumar Azad, Samendra P Archives of Biochemistry and Biophysics.2022; 717: 109124. CrossRef
The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder Virologica Sinica.2022; 37(2): 198. CrossRef
Evolutionary dynamics of SARS-CoV-2 circulating in Yogyakarta and Central Java, Indonesia: sequence analysis covering furin cleavage site (FCS) region of the spike protein Nastiti Wijayanti, Faris Muhammad Gazali, Endah Supriyati, Mohamad Saifudin Hakim, Eggi Arguni, Marselinus Edwin Widyanto Daniwijaya, Titik Nuryastuti, Matin Nuhamunada, Rahma Nabilla, Sofia Mubarika Haryana, Tri Wibawa International Microbiology.2022; 25(3): 531. CrossRef
Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins Boon Zhan Sia, Wan Xin Boon, Yoke Yee Yap, Shalini Kumar, Chong Han Ng F1000Research.2022; 11: 9. CrossRef
The Mutational Landscape of SARS-CoV-2 Variants of Concern Recovered From Egyptian Patients in 2021 Mohamed G. Seadawy, Reem Binsuwaidan, Badriyah Alotaibi, Thanaa A. El-Masry, Bassem E. El-Harty, Ahmed F. Gad, Walid F. Elkhatib, Maisra M. El-Bouseary Frontiers in Microbiology.2022;[Epub] CrossRef
Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019–2022 Nadim Sharif, Khalid J. Alzahrani, Shamsun Nahar Ahmed, Afsana Khan, Hamsa Jameel Banjer, Fuad M. Alzahrani, Anowar Khasru Parvez, Shuvra Kanti Dey, Jayanta Bhattacharya PLOS ONE.2022; 17(8): e0271074. CrossRef
Comparison of Intracellular Transcriptional Response of NHBE Cells to Infection with SARS-CoV-2 Washington and New York Strains Tiana M. Scott, Antonio Solis-Leal, J. Brandon Lopez, Richard A. Robison, Bradford K. Berges, Brett E. Pickett Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far Vivek Chavda, Rajashri Bezbaruah, Kangkan Deka, Lawandashisha Nongrang, Tutumoni Kalita Vaccines.2022; 10(11): 1926. CrossRef
SARS-CoV-2’NİN SÜREGELEN EVRİMİ: PANDEMİNİN SONUNA NE KADAR YAKINIZ? Elmas Pınar KAHRAMAN KILBAŞ, Mustafa ALTINDİŞ Journal of Biotechnology and Strategic Health Rese.2022; 6(3): 201. CrossRef
Complete Genomic Characterisation and Mutation Patterns of Iraqi SARS-CoV-2 Isolates Jivan Qasim Ahmed, Sazan Qadir Maulud Diagnostics.2022; 13(1): 8. CrossRef
Comprehensive annotations of the mutational spectra of SARS‐CoV‐2 spike protein: a fast and accurate pipeline Mohammad Shaminur Rahman, Mohammad Rafiul Islam, Mohammad Nazmul Hoque, Abu Sayed Mohammad Rubayet Ul Alam, Masuda Akther, Joynob Akter Puspo, Salma Akter, Azraf Anwar, Munawar Sultana, Mohammad Anwar Hossain Transboundary and Emerging Diseases.2021; 68(3): 1625. CrossRef
Genomic and proteomic mutation landscapes of SARS‐CoV‐2 Christian Luke D. C. Badua, Karol Ann T. Baldo, Paul Mark B. Medina Journal of Medical Virology.2021; 93(3): 1702. CrossRef
Variant analysis of the first Lebanese SARS-CoV-2 isolates Mhamad Abou-Hamdan, Kassem Hamze, Ali Abdel Sater, Haidar Akl, Nabil El-zein, Israa Dandache, Fadi Abdel-sater Genomics.2021; 113(1): 892. CrossRef
Global SNP analysis of 11,183 SARS‐CoV‐2 strains reveals high genetic diversity Fangfeng Yuan, Liping Wang, Ying Fang, Leyi Wang Transboundary and Emerging Diseases.2021; 68(6): 3288. CrossRef
SARS-CoV-2 hot-spot mutations are significantly enriched within inverted repeats and CpG island loci Pratik Goswami, Martin Bartas, Matej Lexa, Natália Bohálová, Adriana Volná, Jiří Červeň, Veronika Červeňová, Petr Pečinka, Vladimír Špunda, Miroslav Fojta, Václav Brázda Briefings in Bioinformatics.2021; 22(2): 1338. CrossRef
Deciphering the Subtype Differentiation History of SARS-CoV-2 Based on a New Breadth-First Searching Optimized Alignment Method Over a Global Data Set of 24,768 Sequences Qianyu Lin, Yunchuanxiang Huang, Ziyi Jiang, Feng Wu, Lan Ma Frontiers in Genetics.2021;[Epub] CrossRef
Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa Malik Sallam, Nidaa A. Ababneh, Deema Dababseh, Faris G. Bakri, Azmi Mahafzah Heliyon.2021; 7(1): e06035. CrossRef
Environmental aspect and applications of nanotechnology to eliminate COVID-19 epidemiology risk Eman Serag, Marwa El-Zeftawy Nanotechnology for Environmental Engineering.2021;[Epub] CrossRef
Genomic Characterization and Phylogenetic Analysis of SARS-CoV-2 in Libya Silvia Fillo, Francesco Giordani, Anella Monte, Giovanni Faggioni, Riccardo De Santis, Nino D’Amore, Stefano Palomba, Taher Hamdani, Kamel Taloa, Atef Belkhir Jumaa, Siraj Bitrou, Ahmed Alaruusi, Wadie Mad, Abdulaziz Zorgani, Omar Elahmer, Badereddin Anna Microbiology Research.2021; 12(1): 138. CrossRef
SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity Szu-Wei Huang, Sheng-Fan Wang International Journal of Molecular Sciences.2021; 22(6): 3060. CrossRef
Emergence of novel SARS-CoV-2 variants in the Netherlands Aysun Urhan, Thomas Abeel Scientific Reports.2021;[Epub] CrossRef
Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 infectivity Sally Esmail, Wayne R. Danter Computational and Structural Biotechnology Journal.2021; 19: 1701. CrossRef
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak Monire Jamalkhah, Yasaman Asaadi, Mohammadreza Azangou-Khyavy, Javad Khanali, Masoud Soleimani, Jafar Kiani, Ehsan Arefian Journal of Translational Medicine.2021;[Epub] CrossRef
Mutations and Epidemiology of SARS-CoV-2 Compared to Selected Corona Viruses during the First Six Months of the COVID-19 Pandemic: A Review Mirriam M. Nzivo, Nancy L.M. Budambula Journal of Pure and Applied Microbiology.2021; 15(2): 524. CrossRef
The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe Danijela Miljanovic, Ognjen Milicevic, Ana Loncar, Dzihan Abazovic, Dragana Despot, Ana Banko Frontiers in Microbiology.2021;[Epub] CrossRef
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects Lynda Rocheleau, Geneviève Laroche, Kathy Fu, Corina M. Stewart, Abdulhamid O. Mohamud, Marceline Côté, Patrick M. Giguère, Marc-André Langlois, Martin Pelchat, Dimitrios Paraskevis mBio.2021;[Epub] CrossRef
Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance Sagar Dholariya, Deepak Narayan Parchwani, Ragini Singh, Amit Sonagra, Anita Motiani, Digishaben Patel Indian Journal of Clinical Biochemistry.2021; 36(4): 451. CrossRef
Genomic characterization of SARS‐CoV‐2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins Erdem Sahin, Gulendam Bozdayi, Selin Yigit, Hager Muftah, Murat Dizbay, Ozlem G. Tunccan, Isil Fidan, Kayhan Caglar Journal of Medical Virology.2021; 93(10): 6016. CrossRef
Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh Otun Saha, Israt Islam, Rokaiya Nurani Shatadru, Nadira Naznin Rakhi, Md. Shahadat Hossain, Md. Mizanur Rahaman Virus Genes.2021; 57(5): 413. CrossRef
Evolutionary trajectory of SARS-CoV-2 and emerging variants Jalen Singh, Pranav Pandit, Andrew G. McArthur, Arinjay Banerjee, Karen Mossman Virology Journal.2021;[Epub] CrossRef
Molecular characterization of SARS-CoV-2 from Bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations Md. Marufur Rahman, Shirmin Bintay Kader, S.M. Shahriar Rizvi Heliyon.2021; 7(8): e07866. CrossRef
Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations Bilal Ahmad, Maria Batool, Qurat ul Ain, Moon Suk Kim, Sangdun Choi International Journal of Molecular Sciences.2021; 22(17): 9124. CrossRef
Characterization of the SARS-CoV-2 genomes in Egypt in first and second waves of infection Abdel-Rahman N. Zekri, Abeer A. Bahnasy, Mohamed M. Hafez, Zeinab K. Hassan, Ola S. Ahmed, Hany K. Soliman, Enas R. El-Sisi, Mona H. Salah El Dine, May S. Solimane, Lamyaa S. Abdel Latife, Mohamed G. Seadawy, Ahmed S. Elsafty, Mohamed Abouelhoda Scientific Reports.2021;[Epub] CrossRef
A Global Mutational Profile of SARS-CoV-2: A Systematic Review and Meta-Analysis of 368,316 COVID-19 Patients Wardah Yusof, Ahmad Adebayo Irekeola, Yusuf Wada, Engku Nur Syafirah Engku Abd Rahman, Naveed Ahmed, Nurfadhlina Musa, Muhammad Fazli Khalid, Zaidah Abdul Rahman, Rosline Hassan, Nik Yusnoraini Yusof, Chan Yean Yean Life.2021; 11(11): 1224. CrossRef
Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021 Reviany V. Nidom, Setyarina Indrasari, Irine Normalina, Astria N. Nidom, Balqis Afifah, Lestari Dewi, Andra K. Putra, Arif N. M. Ansori, Muhammad K. J. Kusala, Mohammad Y. Alamudi, Chairul A. Nidom Bulletin of the National Research Centre.2021;[Epub] CrossRef
Global Pandemic as a Result of Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak: A Biomedical Perspective Charles Arvind Sethuraman Vairavan, Devarani Rameshnathan, Nagaraja Suryadevara, Gnanendra Shanmugam Journal of Pure and Applied Microbiology.2021; 15(4): 1759. CrossRef
Predicting the Molecular Mechanism of Sini Jia Renshen Decoction in Treating Severe COVID-19 Patients Based on Network Pharmacology and Molecular Docking Yi Wen Liu, Ai Xia Yang, Li Lu, Tie Hua Huang Natural Product Communications.2021;[Epub] CrossRef
Genome Sequencing of SARS-CoV-2 Shashank M. Patil, Ramith Ramu MAMC Journal of Medical Sciences.2021; 7(2): 159. CrossRef
Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity? Aditya K. Padhi, Timir Tripathi ACS Pharmacology & Translational Science.2020; 3(5): 1023. CrossRef
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein Marc C. Johnson, Terri D. Lyddon, Reinier Suarez, Braxton Salcedo, Mary LePique, Maddie Graham, Clifton Ricana, Carolyn Robinson, Detlef G. Ritter, Viviana Simon Journal of Virology.2020;[Epub] CrossRef
A Crowned Killer’s Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2 Shichuan Wang, Mirko Trilling, Kathrin Sutter, Ulf Dittmer, Mengji Lu, Xin Zheng, Dongliang Yang, Jia Liu Virologica Sinica.2020; 35(6): 673. CrossRef
Host or pathogen-related factors in COVID-19 severity? Christian Gortázar, Francisco J Rodríguez del-Río, Lucas Domínguez, José de la Fuente The Lancet.2020; 396(10260): 1396. CrossRef
Host or pathogen-related factors in COVID-19 severity? – Authors' reply Lucy C Okell, Robert Verity, Aris Katzourakis, Erik M Volz, Oliver J Watson, Swapnil Mishra, Patrick Walker, Charlie Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani, Axel Gandy, Seth Flaxman, Neil M Ferguson, Samir Bhatt The Lancet.2020; 396(10260): 1397. CrossRef
Recent updates on COVID-19: A holistic review Shweta Jakhmola, Omkar Indari, Dharmendra Kashyap, Nidhi Varshney, Annu Rani, Charu Sonkar, Budhadev Baral, Sayantani Chatterjee, Ayan Das, Rajesh Kumar, Hem Chandra Jha Heliyon.2020; 6(12): e05706. CrossRef
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation Szu-Wei Huang, Sorin O. Miller, Chia-Hung Yen, Sheng-Fan Wang Genes.2020; 12(1): 16. CrossRef
<b>Objectives</b><br/>
This study aimed to evaluate the specificity, sensitivity, cost, and turn-around time of three methods of gene polymorphism analysis and to study the relationship between IL28B rs12979860 and SVR rate to pegIFN-α/RVB therapy among patients with chronic hepatitis C.<br/><b>Methods</b><br/>
A total of 100 samples from chronic hepatitis C patients were analyzed in parallel using the three methods: direct sequencing, real-time polymerase chain reaction (PCR), amplification refractory mutation system (ARMS)-PCR.<br/><b>Results</b><br/>
The different profiles for IL28B rs12979860 alleles (CC, CT, and TT) obtained with PCR-RFLP, ARMS-PCR, and direct sequencing were consistent among the three methods. Prevalence of rs12979860 genotypes CC, CT and TT in HCV genotype 1a was 10(19.6%), 35(68.6%), and six (11.8%), respectively, and in HCV genotype 31, it was 13(26.5%), 31(63.3%), and five (10.2%), respectively. No significant difference was seen between rs12979860 genotype and HCV genotype (<i>p</i> = 0.710).<br/><b>Conclusion</b><br/>
Screening by ARMS – PCR SNOP detection represents the most efficient and reliable method to determine HCV polymorphisms in routine clinical practice.
Citations
Citations to this article as recorded by
Multiplex Snapshot Minisequencing for the Detection of Common PAH Gene Mutations in Iranian Patients with Phenylketonuria Pegah Namdar Aligoodarzi, Golale Rostami, Seyed Reza Kazemi Nezhad, Mohammad Hamid Iranian Biomedical Journal.2023; 27(1): 46. CrossRef
Expression of
TRIM56
Gene in SARS-CoV-2 Variants and its Relationship with Progression of COVID-19
Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh Future Virology.2023; 18(9): 563. CrossRef
Performance of the tetra-primer PCR technique compared to PCR-RFLP in the search for rs12979860 (C/T) and rs8099917 (T/G) single nucleotide polymorphisms (SNPs) in the IFNL4 gene Ellen Hochleitner Souza Kindermann, Karoline Rodrigues Campos, Adele Caterino-de-Araujo Revista do Instituto Adolfo Lutz.2023; 82: 1. CrossRef
Glioblastoma as a Novel Drug Repositioning Target: Updated State Hamed Hosseinalizadeh, Ammar Ebrahimi, Ahmad Tavakoli, Seyed Hamidreza Monavari Anti-Cancer Agents in Medicinal Chemistry.2023; 23(11): 1253. CrossRef
Prevalence of Human Cytomegalovirus Infection in Iranian Prostate Cancer Patients Ehsan Alborzi, Ahmad Tavakoli, Seyed Jalal Kiani, Saied Ghorbani, Davod Javanmard, Milad Sabaei, Maryam Fatemipour, Seyed Hamidreza Monavari Iranian Journal of Medical Microbiology.2023; 17(4): 379. CrossRef
Performance of the tetra-primer PCR technique compared to PCR-RFLP in the search for rs12979860 (C/T) and rs8099917 (T/G) single nucleotide polymorphisms (SNPs) in the IFNL4 gene Ellen Hochleitner Souza Kindermann, Karoline Rodrigues Campos, Adele Caterino-de-Araujo Revista do Instituto Adolfo Lutz.2023; 82: 1. CrossRef
MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients Mohsen Moghoofei, Sohrab Najafipour, Shayan Mostafaei , Ahmad Tavakoli , Farah Bokharaei-Salim , Saied Ghorbani, Davod Javanmard, Hadi Ghaffari , Seyed Hamidreza Monavari Current HIV Research.2021; 19(1): 27. CrossRef
Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms Amir Hossein Nafari, Ahmad Ayadi, Zahra Noormohamadi, Fatemeh Sakhaee, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh Infection, Genetics and Evolution.2020; 79: 104144. CrossRef
Polymerase Chain Reaction Assay Using the Restriction Fragment Length Polymorphism Technique in the Detection of Prosthetic Joint Infections: A Multi-Centered Study Ataollah Moshirabadi, Mohammad Razi, Peyman Arasteh, Mohammad Mahdi Sarzaeem, Saman Ghaffari, Saied Aminiafshar, Kami Hosseinian Khosroshahy, Fatemeh Maryam Sheikholeslami The Journal of Arthroplasty.2019; 34(2): 359. CrossRef
One-Step ARMS-PCR for the Detection of SNPs—Using the Example of the PADI4 Gene Sabrina Ehnert, Caren Linnemann, Bianca Braun, Josephine Botsch, Karolin Leibiger, Philipp Hemmann, Andreas K. Nussler Methods and Protocols.2019; 2(3): 63. CrossRef
Epstein–Barr Virus and Risk of Breast Cancer: A Systematic Review and Meta-Analysis Mohammad Farahmand, Seyed Hamidreza Monavari, Zabihollah Shoja, Hadi Ghaffari, Mehdi Tavakoli, Ahmad Tavakoli Future Oncology.2019; 15(24): 2873. CrossRef
Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography Eyal Shteyer, Louis Shekhtman, Tal Zinger, Sheri Harari, Inna Gafanovich, Dana Wolf, Hefziba Ivgi, Rima Barsuk, Ilana Dery, Daniela Armoni, Mila Rivkin, Rahul Pipalia, Michal Cohen Eliav, Yizhak Skorochod, Gabriel S. Breuer, Ran Tur-kaspa, Yonit Weil Wien PLOS ONE.2019; 14(1): e0210173. CrossRef
Correlation of CD81 and SCARB1 polymorphisms on virological responses in Iranian patients with chronic hepatitis C virus genotype 1 Milad Nafari, Shiva Irani, Farzam Vaziri, Safoora Gharibzadeh, Fatemeh Sakhaee, Mohammad Khazeni, Naser Kalhor, Fatemeh Rahimi Jamnani, Seyed Davar Siadat, Abolfazl Fateh Infection, Genetics and Evolution.2018; 62: 296. CrossRef
First detection of human hepegivirus-1 (HHpgV-1) in Iranian patients with hemophilia Yazdan Bijvand, Mohammad Reza Aghasadeghi, Fatemeh Sakhaee, Parviz Pakzad, Farzam Vaziri, Alireza Azizi Saraji, Fatemeh Rahimi Jamnani, Seyed Davar Siadat, Abolfazl Fateh Scientific Reports.2018;[Epub] CrossRef
Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection Setareh Mobasheri, Nazanin Irani, Abbas Akhavan Sepahi, Fatemeh Sakhaee, Fatemeh Rahimi Jamnani, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh Gene.2018; 676: 95. CrossRef
Data Mining and Machine Learning Algorithms Using IL28B Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C Hend Ibrahim Shousha, Abubakr Hussein Awad, Dalia Abdelhamid Omran, Mayada Mohamed Elnegouly, Mahasen Mabrouk Japanese Journal of Infectious Diseases.2018; 71(1): 51. CrossRef
IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C Parvaneh Sedighimehr, Shiva Irani, Fatemeh Sakhaee, Farzam Vaziri, Mohammadreza Aghasadeghi, Seyed Mehdi Sadat, Fatemeh Rahimi Jamnani, Abolfazl Fateh, Seyed Davar Siadat Archives of Virology.2017; 162(1): 181. CrossRef
Comparison of Direct Sequencing, Real-Time PCR-High Resolution Melt (PCR-HRM) and PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) Analysis for Genotyping of Common Thiopurine Intolerant Variant Alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) Wai-Ying Fong, Chi-Chun Ho, Wing-Tat Poon Diagnostics.2017; 7(2): 27. CrossRef
Effect of IL15 rs10833 and SCARB1 rs10846744 on virologic responses in chronic hepatitis C patients treated with pegylated interferon-α and ribavirin Sahar Sadeghi, Mehdi Davari, Esmaeil Asli, Safoora Gharibzadeh, Farzam Vaziri, Fatemeh Rahimi Jamnani, Abolfazl Fateh, Seyed Davar Siadat Gene.2017; 630: 28. CrossRef
High platelet count and high probability of CALR detection in myeloproliferative neoplasms Reza Shirzad, Zari Tahan-nejad, Javad Mohamadi-asl, Mohammad Seghatoleslami, Ahmad Ahmadzadeh, Amal Saki Malehi, Najmaldin Saki Comparative Clinical Pathology.2017; 26(1): 25. CrossRef
A comparative study of various methods for detection ofIL28Brs12979860 in chronic hepatitis C Seyed Hamidreza Monavari, Roohollah Fateh, Farzam Vaziri, Fatemeh Rahimi Jamnani, Enayat Anvari, Farzin Sadeghi, Parviz Afrough, Ava Behrouzi, Fatemeh Sakhaee, Sepideh Meidaninikjeh, Hamidreza Mollaie, Alireza Hadizadeh Tasbiti, Shamsi Yari, Maryam Sadegh Scandinavian Journal of Clinical and Laboratory In.2017; 77(4): 247. CrossRef
EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C M Asnavandi, M Zargar, F Vaziri, F R Jamnani, S Gharibzadeh, A Fateh, S D Siadat Genes & Immunity.2017; 18(3): 144. CrossRef
Genetic Variation in Interleukin-28B and Response to Peg-IFNα-2a/RBV Combination Therapy in Patients with Hepatitis C Virus Infection Farah Bokharaei-Salim, Mostafa Salehi-Vaziri, Farzin Sadeghi, Khadijeh Khanaliha, Maryam Esghaei, Seyed Hamidreza Monavari, Seyed Moayed Alavian, Shahin Fakhim, Hossein Keyvani Jundishapur Journal of Microbiology.2016;[Epub] CrossRef
<b>Objectives</b><br/>
In this study, the viral fitness of pseudo-viruses with a drug-resistant site in the reverse transcriptase (RT) region of the genome was investigated. The pseudo-viruses were derived from highly active antiretroviral therapy (HAART)-experienced HIV/AIDS patients.<br/><b>Methods</b><br/>
HIV-1 RNA was extracted from the plasma of HAART-experienced (KRB9149, KRB7021, KRC1097) and HAART-naïve (KRC5180, KRC5123) HIV-1 patients. The RT gene from the extracted viral RNA was amplified and the polymerase chain reaction product was cloned from the pHXB2Δ2-261 RT vector. C8166 and TZM-bl cell lines were used as the HIV-1 replication capacity measurement system. To quantify the infectivity of homologous recombinant HIV-1, the infectivity derived from each pseudo-virus was compared with the infectivity of the reference strain HXB2.<br/><b>Results</b><br/>
Patient-derived HIV-1 was cotransfected into C8166 cells and the expression level of the p24 antigen was measured. The expression was high in the HIV-1 isolates from patients KRC5180 and KRB9149 and low in patients KRB7021, KRC5123, and KRC1097, when compared with the reference strain. The infectivity of the pseudo-virus measured in TZM-bl cells decreased in the order, reference strain HXB2 > KRC5180 > KRC5123 > KRB9149 > KRB7021 > KRC1097.<br/><b>Conclusion</b><br/>
In this study, HIV-1 infectivity of the drug-resistant strain isolated from HAART-experienced patients with HIV/AIDS was found to be lower than the infectivity of the reference strain HXB2. This study provides useful data for the phenotypic susceptibility assay in HAART-experienced patients infected with HIV-1.
Citations
Citations to this article as recorded by
Development and application of a high-titer VSV-based HCoV-NL63 pseudovirus system via C-terminal 14 amino acid truncation of spike Li-ting Shao, Ming-ming Wang, Yi-ming Wang, Tian Li, Fei Wang, Jie-rong Xin, Xin Zhang, Wei-guo Li, Xue-jun Wang, Sheng-qi Wang Biochemical and Biophysical Research Communication.2025; 751: 151458. CrossRef
Discrimination and Stigma Hae-Wol Cho, Chaeshin Chu Osong Public Health and Research Perspectives.2015; 6(3): 141. CrossRef
What is Next for HIV/AIDS in Korea? Hae-Wol Cho, Chaeshin Chu Osong Public Health and Research Perspectives.2013; 4(6): 291. CrossRef
The Road Less Traveled Chaeshin Chu Osong Public Health and Research Perspectives.2011; 2(1): 1. CrossRef
First
Prev
